Michael Gleason

Mr. Gleason is a private investor residing in London, U.K, and Dublin, Ireland. He is originally from Midland, Texas. He has had interests in oil & gas production, real estate, media and consumer products.

Mr. Gleason was Chairman and CEO of Change Technology Partners, Inc. (CTPI OTC BB), a public company based in Greenwich, CT. In August 2003, he orchestrated CTPI’s merger with Neurologix, Inc. (NRGX.OB), a company conducting surgical trials of gene therapy to treat Parkinson’s Disease. He subsequently served as a consultant to Neurologix and helped raise an additional round of finance. In June 2010, Neurologix announced the successful completion of Phase II of their testing.

In August 2000, Mr. Gleason was re-elected to the board of directors of Metro-Goldwyn-Mayer, Inc. He also served on the MGM board from October 1996 through September 1998. He left MGM’s Board after private equity investors acquired the company in April 2005.

He was also an original investor in and a member of the board of directors of Fresh, Inc., a Boston, MA beauty products maker partially acquired by LVMH in September 2000. He disposed of his remaining interests in Fresh in November 2006.

In 2005, Mr. Gleason formed Live from Abbey Road Ltd., which produces the award winning television series of the same name. He has produced 36 episodes of the series so far, and the show enjoys distribution in 112 countries around the world.

Mr. Gleason served on the Executive Committee of the Board of the Fort Worth, Texas Zoological Association from 1989 to 2001 and is a former trustee of Fort Worth Country Day School. In June 2000, he was elected to the board of The Peregrine Fund, Boise, Idaho, for a three-year term.

He is a 1976 graduate of Duke University.